(Q50474760)

English

Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib.

scientific article published on 2 April 2014

Statements

Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit